Frazier Life Sciences Management, L.P. Portfolio Holdings

Frazier Life Sciences Management, L.P.

  • $1.86 Billion
  • Q3 2024

Frazier Life Sciences Management, L.P. has filed its 13F form on November 15, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.86 Billion distributed in 53 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Mirum Pharmaceuticals, Inc. with a value of $256M, Phathom Pharmaceuticals, Inc. with a value of $183M, Krystal Biotech, Inc. with a value of $180M, Rhythm Pharmaceuticals, Inc. with a value of $127M, and Vaxcyte, Inc. with a value of $100M.

Examining the 13F form we can see an increase of $161M in the current position value, from $1.7B to 1.86B.

Frazier Life Sciences Management, L.P. is based out at Menlo Park, CA

Below you can find more details about Frazier Life Sciences Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $1.86 Billion
Healthcare: $1.86 Billion

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.61B
$256 Million 13.79% of portfolio
6,570,392
Q3 2024 Added 1.15%
$342M
$183 Million 9.84% of portfolio
10,109,279
Q2 2023 Added 20.25%
$4.57B
$180 Million 9.67% of portfolio
988,460
Q3 2023 Reduced 0.18%
$3.34B
$127 Million 6.82% of portfolio
2,416,952
Q3 2024 Added 1.93%
$5.1B
$100 Million 5.4% of portfolio
879,405
Q3 2024 Reduced 15.39%
$2.37B
$97.4 Million 5.24% of portfolio
3,383,950
Q3 2024 Added 2.1%
$3.42B
$95.7 Million 5.15% of portfolio
3,760,457
Q3 2024 Added 3.52%
$613M
$81.7 Million 4.4% of portfolio
8,785,284
Q1 2024 Added 0.24%
$2.02B
$75.6 Million 4.07% of portfolio
2,832,867
Q3 2024 Reduced 24.07%
$322M
$52.9 Million 2.85% of portfolio
19,391,687
Q3 2024 Added 19.58%
$1.24B
$52.2 Million 2.81% of portfolio
1,587,527
Q2 2024 Reduced 11.19%
$2.99B
$46.4 Million 2.5% of portfolio
1,044,154
Q3 2024 Added 19.75%
$5B
$45.2 Million 2.43% of portfolio
997,455
Q3 2023 Added 16.73%
$220M
$42.7 Million 2.3% of portfolio
3,687,867
Q1 2024 Added 1.81%
$346M
$42.5 Million 2.29% of portfolio
4,142,855
Q1 2024 Added 93.33%
$3.25B
$35.2 Million 1.89% of portfolio
633,715
Q3 2024 Added 49.11%
$987M
$27.4 Million 1.48% of portfolio
1,485,630
Q3 2024 Reduced 4.84%
$162M
$24.7 Million 1.33% of portfolio
7,381,090
Q4 2023 Added 7.27%
$447M
$21 Million 1.13% of portfolio
5,097,779
Q3 2024 Added 15.82%
$249M
$20.9 Million 1.12% of portfolio
1,148,591
Q1 2024 Added 30.35%
$6.94B
$19.9 Million 1.07% of portfolio
133,333
Q3 2024 New
$60.5M
$18.7 Million 1.01% of portfolio
10,617,062
Q2 2024 Added 8.54%
$1.97B
$18.6 Million 1.0% of portfolio
373,100
Q2 2024 Reduced 50.02%
$666M
$17.2 Million 0.92% of portfolio
731,020
Q3 2024 Reduced 12.16%
$255M
$16.8 Million 0.9% of portfolio
4,623,324
Q1 2024 Added 23.39%
$4.58B
$16.1 Million 0.87% of portfolio
576,129
Q3 2024 New
$595M
$15.5 Million 0.83% of portfolio
1,354,711
Q3 2024 Added 17.55%
$306M
$10.2 Million 0.55% of portfolio
1,892,547
Q3 2024 Added 58.35%
$597M
$10.1 Million 0.54% of portfolio
936,576
Q1 2024 Reduced 53.06%
$202M
$9.91 Million 0.53% of portfolio
3,010,727
Q2 2024 Added 21.81%
$1B
$9.61 Million 0.52% of portfolio
689,655
Q3 2024 New
$295M
$8.03 Million 0.43% of portfolio
2,867,750
Q1 2024 New
$123M
$7.81 Million 0.42% of portfolio
3,062,558
Q2 2024 Added 8.74%
$371M
$7.4 Million 0.4% of portfolio
1,000,000
Q1 2024 Reduced 50.0%
$2.63B
$7.24 Million 0.39% of portfolio
470,338
Q1 2024 Reduced 35.65%
$1.21B
$7.03 Million 0.38% of portfolio
285,331
Q2 2022 Added 5.55%
$106M
$6.01 Million 0.32% of portfolio
702,694
Q3 2024 Reduced 53.24%
$13.7M
$3.6 Million 0.19% of portfolio
5,993,579
Q3 2024 Added 102.58%
$1.42B
$3.39 Million 0.18% of portfolio
108,762
Q2 2024 New
$560M
$2.8 Million 0.15% of portfolio
1,218,236
Q3 2024 New
$264M
$298,000 0.02% of portfolio
264,377
Q1 2023 Reduced 8.89%
-
$0 0.0% of portfolio
-
Q4 2022 New
-
$0 0.0% of portfolio
-
Q3 2024 Added 5.14%

Summary

  • Portfolio
  • No. of Stocks 53
  • Current Value $1.86 Billion
  • Prior Value $1.7 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 15, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 8 stocks
  • Additional Purchases 13 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Frazier Life Sciences Management, L.P. Portfolio

Follow Frazier Life Sciences Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email